How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia.
Identifieur interne : 000293 ( Main/Exploration ); précédent : 000292; suivant : 000294How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia.
Auteurs : H. Von Baum [Allemagne] ; B. Schweiger ; T. Welte ; R. Marre ; N. Suttorp ; M W R. Pletz ; S. EwigSource :
- The European respiratory journal [ 1399-3003 ] ; 2011.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Allemagne (épidémiologie), Antibactériens (usage thérapeutique), Femelle, Grippe humaine (diagnostic), Grippe humaine (mortalité), Grippe humaine (virologie), Humains, Incidence, Infections communautaires (diagnostic), Infections communautaires (mortalité), Infections communautaires (traitement médicamenteux), Infections communautaires (virologie), Infections à pneumocoques (diagnostic), Infections à pneumocoques (mortalité), Infections à pneumocoques (traitement médicamenteux), Mâle, Pneumopathie virale (diagnostic), Pneumopathie virale (microbiologie), Pneumopathie virale (mortalité), Pneumopathie virale (traitement médicamenteux), Sujet âgé, Études prospectives.
- MESH :
- diagnostic : Grippe humaine, Infections communautaires, Infections à pneumocoques, Pneumopathie virale.
- microbiologie : Pneumopathie virale.
- mortalité : Grippe humaine, Infections communautaires, Infections à pneumocoques, Pneumopathie virale.
- traitement médicamenteux : Infections communautaires, Infections à pneumocoques, Pneumopathie virale.
- usage thérapeutique : Antibactériens.
- virologie : Grippe humaine, Infections communautaires.
- épidémiologie : Allemagne.
- Adulte, Adulte d'âge moyen, Femelle, Humains, Incidence, Mâle, Sujet âgé, Études prospectives.
- Wicri :
- geographic : Allemagne.
English descriptors
- KwdEn :
- Adult, Aged, Anti-Bacterial Agents (therapeutic use), Community-Acquired Infections (diagnosis), Community-Acquired Infections (drug therapy), Community-Acquired Infections (mortality), Community-Acquired Infections (virology), Female, Germany (epidemiology), Humans, Incidence, Influenza, Human (diagnosis), Influenza, Human (mortality), Influenza, Human (virology), Male, Middle Aged, Pneumococcal Infections (diagnosis), Pneumococcal Infections (drug therapy), Pneumococcal Infections (mortality), Pneumonia, Viral (diagnosis), Pneumonia, Viral (drug therapy), Pneumonia, Viral (microbiology), Pneumonia, Viral (mortality), Prospective Studies.
- MESH :
- chemical , therapeutic use : Anti-Bacterial Agents.
- geographic , epidemiology : Germany.
- diagnosis : Community-Acquired Infections, Influenza, Human, Pneumococcal Infections, Pneumonia, Viral.
- drug therapy : Community-Acquired Infections, Pneumococcal Infections, Pneumonia, Viral.
- microbiology : Pneumonia, Viral.
- mortality : Community-Acquired Infections, Influenza, Human, Pneumococcal Infections, Pneumonia, Viral.
- virology : Community-Acquired Infections, Influenza, Human.
- Adult, Aged, Female, Humans, Incidence, Male, Middle Aged, Prospective Studies.
Abstract
The emergence of new influenza virus subtypes has rekindled the interest in the clinical course and outcome of patients with influenza-associated pneumonia. Based on prospective data from 5,032 patients with community-acquired pneumonia (CAP) included in the German Competence Network for Community-Acquired Pneumonia (CAPNETZ), we studied the incidence, clinical characteristics and outcome of patients with influenza-associated CAP and compared these findings with patients without influenza. Diagnosis relied on a positive PCR for influenza in throat washings. 160 patients with influenza-associated CAP were identified (3.2% of total population, 12% of those with defined aetiology). 34 (21%) patients with seasonal influenza had a concomitant pathogen (mostly Streptococcus pneumoniae). Patients with influenza-associated CAP were significantly older, had been vaccinated less often and had preceding antibacterial treatment less often. 30-day mortality was low (4.4%) and not different to that of patients with pneumonia caused by bacterial (6.2%) or viral (other than influenza) pathogens (4%). Patients with influenza plus a bacterial pathogen (mixed influenza-associated pneumonia) had a higher mortality than those with pure influenza-associated pneumonia (9% versus 3.2%). Mortality was higher in patients with mixed compared with pure influenza-associated pneumonia. However, we could not observe any excess mortality in patients with influenza-associated pneumonia.
DOI: 10.1183/09031936.00037410
PubMed: 20817703
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia.</title><author><name sortKey="Von Baum, H" sort="Von Baum, H" uniqKey="Von Baum H" first="H" last="Von Baum">H. Von Baum</name><affiliation wicri:level="3"><nlm:affiliation>Institute for Medical Microbiology and Hygiene, University Hospital of Ulm, Ulm, Germany. heike.von-baum@uniklinik-ulm.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute for Medical Microbiology and Hygiene, University Hospital of Ulm, Ulm</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Ulm</settlement></placeName></affiliation></author><author><name sortKey="Schweiger, B" sort="Schweiger, B" uniqKey="Schweiger B" first="B" last="Schweiger">B. Schweiger</name></author><author><name sortKey="Welte, T" sort="Welte, T" uniqKey="Welte T" first="T" last="Welte">T. Welte</name></author><author><name sortKey="Marre, R" sort="Marre, R" uniqKey="Marre R" first="R" last="Marre">R. Marre</name></author><author><name sortKey="Suttorp, N" sort="Suttorp, N" uniqKey="Suttorp N" first="N" last="Suttorp">N. Suttorp</name></author><author><name sortKey="Pletz, M W R" sort="Pletz, M W R" uniqKey="Pletz M" first="M W R" last="Pletz">M W R. Pletz</name></author><author><name sortKey="Ewig, S" sort="Ewig, S" uniqKey="Ewig S" first="S" last="Ewig">S. Ewig</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:20817703</idno><idno type="pmid">20817703</idno><idno type="doi">10.1183/09031936.00037410</idno><idno type="wicri:Area/Main/Corpus">000322</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000322</idno><idno type="wicri:Area/Main/Curation">000322</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000322</idno><idno type="wicri:Area/Main/Exploration">000322</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia.</title><author><name sortKey="Von Baum, H" sort="Von Baum, H" uniqKey="Von Baum H" first="H" last="Von Baum">H. Von Baum</name><affiliation wicri:level="3"><nlm:affiliation>Institute for Medical Microbiology and Hygiene, University Hospital of Ulm, Ulm, Germany. heike.von-baum@uniklinik-ulm.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Institute for Medical Microbiology and Hygiene, University Hospital of Ulm, Ulm</wicri:regionArea><placeName><region type="land" nuts="1">Bade-Wurtemberg</region><region type="district" nuts="2">District de Tübingen</region><settlement type="city">Ulm</settlement></placeName></affiliation></author><author><name sortKey="Schweiger, B" sort="Schweiger, B" uniqKey="Schweiger B" first="B" last="Schweiger">B. Schweiger</name></author><author><name sortKey="Welte, T" sort="Welte, T" uniqKey="Welte T" first="T" last="Welte">T. Welte</name></author><author><name sortKey="Marre, R" sort="Marre, R" uniqKey="Marre R" first="R" last="Marre">R. Marre</name></author><author><name sortKey="Suttorp, N" sort="Suttorp, N" uniqKey="Suttorp N" first="N" last="Suttorp">N. Suttorp</name></author><author><name sortKey="Pletz, M W R" sort="Pletz, M W R" uniqKey="Pletz M" first="M W R" last="Pletz">M W R. Pletz</name></author><author><name sortKey="Ewig, S" sort="Ewig, S" uniqKey="Ewig S" first="S" last="Ewig">S. Ewig</name></author></analytic><series><title level="j">The European respiratory journal</title><idno type="eISSN">1399-3003</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Anti-Bacterial Agents (therapeutic use)</term><term>Community-Acquired Infections (diagnosis)</term><term>Community-Acquired Infections (drug therapy)</term><term>Community-Acquired Infections (mortality)</term><term>Community-Acquired Infections (virology)</term><term>Female</term><term>Germany (epidemiology)</term><term>Humans</term><term>Incidence</term><term>Influenza, Human (diagnosis)</term><term>Influenza, Human (mortality)</term><term>Influenza, Human (virology)</term><term>Male</term><term>Middle Aged</term><term>Pneumococcal Infections (diagnosis)</term><term>Pneumococcal Infections (drug therapy)</term><term>Pneumococcal Infections (mortality)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (microbiology)</term><term>Pneumonia, Viral (mortality)</term><term>Prospective Studies</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Allemagne (épidémiologie)</term><term>Antibactériens (usage thérapeutique)</term><term>Femelle</term><term>Grippe humaine (diagnostic)</term><term>Grippe humaine (mortalité)</term><term>Grippe humaine (virologie)</term><term>Humains</term><term>Incidence</term><term>Infections communautaires (diagnostic)</term><term>Infections communautaires (mortalité)</term><term>Infections communautaires (traitement médicamenteux)</term><term>Infections communautaires (virologie)</term><term>Infections à pneumocoques (diagnostic)</term><term>Infections à pneumocoques (mortalité)</term><term>Infections à pneumocoques (traitement médicamenteux)</term><term>Mâle</term><term>Pneumopathie virale (diagnostic)</term><term>Pneumopathie virale (microbiologie)</term><term>Pneumopathie virale (mortalité)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Sujet âgé</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Germany</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Community-Acquired Infections</term><term>Influenza, Human</term><term>Pneumococcal Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Grippe humaine</term><term>Infections communautaires</term><term>Infections à pneumocoques</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Community-Acquired Infections</term><term>Pneumococcal Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Community-Acquired Infections</term><term>Influenza, Human</term><term>Pneumococcal Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Grippe humaine</term><term>Infections communautaires</term><term>Infections à pneumocoques</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections communautaires</term><term>Infections à pneumocoques</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term><term>Infections communautaires</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Community-Acquired Infections</term><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Sujet âgé</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The emergence of new influenza virus subtypes has rekindled the interest in the clinical course and outcome of patients with influenza-associated pneumonia. Based on prospective data from 5,032 patients with community-acquired pneumonia (CAP) included in the German Competence Network for Community-Acquired Pneumonia (CAPNETZ), we studied the incidence, clinical characteristics and outcome of patients with influenza-associated CAP and compared these findings with patients without influenza. Diagnosis relied on a positive PCR for influenza in throat washings. 160 patients with influenza-associated CAP were identified (3.2% of total population, 12% of those with defined aetiology). 34 (21%) patients with seasonal influenza had a concomitant pathogen (mostly Streptococcus pneumoniae). Patients with influenza-associated CAP were significantly older, had been vaccinated less often and had preceding antibacterial treatment less often. 30-day mortality was low (4.4%) and not different to that of patients with pneumonia caused by bacterial (6.2%) or viral (other than influenza) pathogens (4%). Patients with influenza plus a bacterial pathogen (mixed influenza-associated pneumonia) had a higher mortality than those with pure influenza-associated pneumonia (9% versus 3.2%). Mortality was higher in patients with mixed compared with pure influenza-associated pneumonia. However, we could not observe any excess mortality in patients with influenza-associated pneumonia.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20817703</PMID><DateCompleted><Year>2011</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2013</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Month>May</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur. Respir. J.</ISOAbbreviation></Journal><ArticleTitle>How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia.</ArticleTitle><Pagination><MedlinePgn>1151-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1183/09031936.00037410</ELocationID><Abstract><AbstractText>The emergence of new influenza virus subtypes has rekindled the interest in the clinical course and outcome of patients with influenza-associated pneumonia. Based on prospective data from 5,032 patients with community-acquired pneumonia (CAP) included in the German Competence Network for Community-Acquired Pneumonia (CAPNETZ), we studied the incidence, clinical characteristics and outcome of patients with influenza-associated CAP and compared these findings with patients without influenza. Diagnosis relied on a positive PCR for influenza in throat washings. 160 patients with influenza-associated CAP were identified (3.2% of total population, 12% of those with defined aetiology). 34 (21%) patients with seasonal influenza had a concomitant pathogen (mostly Streptococcus pneumoniae). Patients with influenza-associated CAP were significantly older, had been vaccinated less often and had preceding antibacterial treatment less often. 30-day mortality was low (4.4%) and not different to that of patients with pneumonia caused by bacterial (6.2%) or viral (other than influenza) pathogens (4%). Patients with influenza plus a bacterial pathogen (mixed influenza-associated pneumonia) had a higher mortality than those with pure influenza-associated pneumonia (9% versus 3.2%). Mortality was higher in patients with mixed compared with pure influenza-associated pneumonia. However, we could not observe any excess mortality in patients with influenza-associated pneumonia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>von Baum</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Medical Microbiology and Hygiene, University Hospital of Ulm, Ulm, Germany. heike.von-baum@uniklinik-ulm.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schweiger</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Welte</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Marre</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Suttorp</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Pletz</LastName><ForeName>M W R</ForeName><Initials>MW</Initials></Author><Author ValidYN="Y"><LastName>Ewig</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><CollectiveName>CAPNETZ Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011008" MajorTopicYN="N">Pneumococcal Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Rohde</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hauptmeier</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schaberg</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hering</LastName><ForeName>I</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dalhoff</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heyer</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schumann</LastName><ForeName>C</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bauer</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kunitz</LastName><ForeName>F</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schütte</LastName><ForeName>H</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tessmer</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rademacher</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gillissen</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drewelow</LastName><ForeName>B</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Majcher-Peszynska</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krüger</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bals</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martus</LastName><ForeName>P</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Illmann</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallner</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barten</LastName><ForeName>G</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gosman</LastName><ForeName>L</ForeName><Initials>L</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20817703</ArticleId><ArticleId IdType="pii">09031936.00037410</ArticleId><ArticleId IdType="doi">10.1183/09031936.00037410</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country><region><li>Bade-Wurtemberg</li><li>District de Tübingen</li></region><settlement><li>Ulm</li></settlement></list><tree><noCountry><name sortKey="Ewig, S" sort="Ewig, S" uniqKey="Ewig S" first="S" last="Ewig">S. Ewig</name><name sortKey="Marre, R" sort="Marre, R" uniqKey="Marre R" first="R" last="Marre">R. Marre</name><name sortKey="Pletz, M W R" sort="Pletz, M W R" uniqKey="Pletz M" first="M W R" last="Pletz">M W R. Pletz</name><name sortKey="Schweiger, B" sort="Schweiger, B" uniqKey="Schweiger B" first="B" last="Schweiger">B. Schweiger</name><name sortKey="Suttorp, N" sort="Suttorp, N" uniqKey="Suttorp N" first="N" last="Suttorp">N. Suttorp</name><name sortKey="Welte, T" sort="Welte, T" uniqKey="Welte T" first="T" last="Welte">T. Welte</name></noCountry><country name="Allemagne"><region name="Bade-Wurtemberg"><name sortKey="Von Baum, H" sort="Von Baum, H" uniqKey="Von Baum H" first="H" last="Von Baum">H. Von Baum</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeAllemagneV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000293 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000293 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeAllemagneV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:20817703
|texte= How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20817703" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV3
| This area was generated with Dilib version V0.6.35. |  |